Department of Medicine 3 – Rheumatology and Immunology

Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial (2020) Baraliakos X, Gossec L, Pournara E, Jeka S, Blanco R, D'Angelo S, Schett G, et al. Conference contribution Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (2020) Rech J, Schenker H, Tascilar K, Hagen M, Kleyer A, Simon D, Mendez LV, et al. Conference contribution Machine Learning Identifies an Association Between Pre-existing Radiographic Damage and Long-term Clinical Outcomes with Secukinumab Therapy in Patients with Psoriatic Arthritis (2020) Mease P, Van Der Heijde D, Kirkham B, Schett G, Orbai AM, Ritchlin C, Merola J, et al. Conference contribution Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib (2020) Matteson E, Distler O, Distler J, Kuwana M, Pope J, Seibold J, James A, et al. Conference contribution Microbiota-induced Intestinal Barrier Dysfunction Initiates the Shuttling of Immune Cells from the Gut to the Joints (2020) Tajik N, Frech M, Brandl C, Canete J, Ciccia F, Schett G, Zaiss M Conference contribution Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks (2020) Schett G, Van Den Bosch F, Baraliakos X, Sandoval D, Geneus V, Bolce R, Liu-Leage S, et al. Conference contribution A Phase IIb, Randomized, Double-blind Study in Patients with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Patients with an Inadequate Response to Methotrexate (2020) Peterfy C, Buch M, Choy E, Schett G, Parsons-Rich D, Patel A, Zima Y, et al. Conference contribution Collagen Turnover Markers Are Associated with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase-3 Clinical Trial (2020) Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Baribaud F, Sweet K Conference contribution Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Conference contribution High Impact Sports Leads to Inflammatory Responses at Entheseal Sites Results of the BEAT Study (Badminton Enthesitis Arthrosonography Study) (2020) Simon D, Kleyer A, Tascilar K, Bayat S, Knitza J, Valor-Mendez L, Schweiger M, et al. Conference contribution